Mesothelioma

This is a type of cancer that starts in the thin layer of tissue lining some of your organs, like the lungs (pleura) or the abdomen (peritoneum). It's often linked to exposure to asbestos fibers.

Condition

What people with Mesothelioma report

Every report comes from a Lived member, sent anonymously.

Have you tried Opdivo (Nivolumab) for Mesothelioma?

NameHow it went

About Mesothelioma

What It Is

Mesothelioma is a cancer that starts in the mesothelium, the thin layer of tissue that lines the chest, the abdomen and the sac around the heart. Most cases begin in the pleura, the lining that covers the lungs and the inside of the chest wall, and are called pleural mesothelioma. A smaller share start in the peritoneum, the lining of the abdomen. Rarely, it forms around the heart or a testicle. Mesothelioma is rare, with about 3,000 new cases a year in the United States, but it is a serious cancer. Pleural mesothelioma typically causes shortness of breath, pain under the rib cage and a cough, often because fluid collects between the lung and the chest wall and keeps the lung from fully expanding. Peritoneal mesothelioma tends to cause abdominal pain, swelling or lumps. Fatigue and weight loss without a clear reason are common with both. These symptoms build gradually and resemble far more common illnesses, which is one reason the disease is easy to miss early.

Causes & Risk Factors

Asbestos is by far the most important cause. Asbestos is a group of natural minerals made of tiny fibers that were widely used in insulation and building materials because they resist heat and fire. When the fibers are inhaled, some lodge in the lungs and work their way into the pleura, where they injure cells over many years. Fibers that are coughed up and swallowed can reach the lining of the abdomen. A history of asbestos exposure is found in roughly 70 to 80 percent of people with mesothelioma. The cancer usually appears 20 to 50 years after the first exposure, and the risk does not fade once exposure stops. That long delay is why most people diagnosed are older: the average age for pleural mesothelioma is about 70. The people at highest risk worked in jobs such as shipyards, construction, insulation, plumbing, mining, factories, railroads and auto repair, often decades ago. Family members could be exposed to fibers carried home on work clothes. Asbestos that stays intact in older buildings poses little risk unless it is disturbed, for example during renovation or removal. Exposure raises risk but does not make the disease inevitable. Most people exposed to asbestos, even in large amounts, never develop mesothelioma, and some people with mesothelioma have no known exposure. Other contributors include earlier high-dose radiation treatment to the chest or abdomen, erionite (a mineral related to asbestos found in some soils), and, rarely, an inherited change in the BAP1 gene that runs in families. Mesothelioma is much more common in men, largely because more men worked in high-exposure jobs.

How It's Diagnosed

Diagnosis starts with symptoms, a physical exam and a detailed history of jobs and places lived. Asbestos exposure decades ago is an important clue that people often don't think to mention. A chest X-ray or CT scan (a detailed set of X-ray images) may show thickening of the lining around the lung or a collection of fluid. Imaging can raise suspicion but cannot confirm mesothelioma. A pathologist has to examine cells or tissue under a microscope. Fluid drained from the chest or abdomen is often tested first, but it frequently does not give a definite answer, so a tissue biopsy is usually needed. In the chest this is often done by thoracoscopy, in which a surgeon passes a thin camera through a small cut between the ribs to look at the lining and take samples. A similar camera procedure is used for the abdomen. Special stains on the sample help separate mesothelioma from lung cancer or cancer that has spread from elsewhere, which can look very similar under the microscope. The report also names the cell type. Epithelioid mesothelioma, about 60 percent of cases, generally has a better outlook than the sarcomatoid or biphasic (mixed) types. Further tests then establish the stage, meaning how far the cancer has spread, which guides treatment. Because the disease is uncommon and hard to diagnose, getting a second opinion on the pathology and the treatment plan from a center experienced with mesothelioma is common and reasonable.

Treatment Options

Treatment depends on where the cancer started, its stage and cell type, and a person's overall health and lung function. Because mesothelioma is usually found after it has spread along the lining, treatment for most people aims to control the cancer for as long as possible and to keep breathing, pain and energy manageable, rather than to remove every cancer cell. For pleural mesothelioma that cannot be removed with surgery, the first treatment is usually medicine given by infusion into a vein. One approved option is immunotherapy with nivolumab (Opdivo) plus ipilimumab (Yervoy), two drugs that release natural brakes on the immune system so it can attack cancer cells. In the main trial, this combination lengthened median survival to about 18 months, compared with about 14 months with chemotherapy. Another approved option adds the immunotherapy drug pembrolizumab (Keytruda) to chemotherapy with pemetrexed and a platinum drug. Chemotherapy with pemetrexed and a platinum drug such as cisplatin, sometimes with bevacizumab (a drug that blocks the signals tumors use to grow new blood vessels), remains a standard choice. Cell type, overall health and personal priorities help decide among them. Immunotherapy's side effects differ from chemotherapy's. Because it switches on the immune system, it can inflame healthy organs such as the lungs, bowel, liver, skin or hormone-producing glands. These reactions can be serious, so blood tests are checked regularly during treatment and new symptoms are reported promptly so they can be treated early. Surgery is considered for some people with early pleural disease who are fit enough for a major operation. Pleurectomy and decortication removes the lining around the lung and visible tumor while keeping the lung. Extrapleural pneumonectomy is a much larger operation that also removes the whole lung, part of the diaphragm and the lining around the heart. Surgery is usually combined with chemotherapy or radiation, and results are better at centers experienced with mesothelioma. For peritoneal mesothelioma that has not spread beyond the abdomen, carefully selected people may have cytoreductive surgery, which removes all visible tumor, followed by HIPEC (hyperthermic intraperitoneal chemotherapy), in which heated chemotherapy is circulated through the abdomen during the operation. At experienced centers, selected people have lived a median of three to four years after this approach, although the evidence comes mostly from single-center reports rather than controlled trials. Chemotherapy is used when surgery is not possible. Relieving symptoms is part of care at every stage. Fluid around the lung can be drained to ease breathlessness, and pleurodesis, a procedure that seals the space between the lung and chest wall, can stop it from building up again. Radiation can relieve pain, and palliative care specialists help with pain, breathlessness and fatigue alongside cancer treatment. Because treatment choices remain limited, clinical trials are worth asking about.

What to Expect

Mesothelioma is often found when it is already advanced, which makes it harder to treat, and for most people it is a serious, life-limiting illness. Outlook varies widely, though. Stage, cell type, age, general health and whether the tumor can be removed all matter, and people with epithelioid tumors and early-stage disease generally do better. Published survival statistics come from people treated years ago, before current immunotherapy, so they describe groups rather than predicting any one person's course. During treatment, people have infusions on a regular schedule and repeat scans to see whether the cancer is responding. Those results guide decisions to continue, change or pause treatment, and checkups and scans continue after treatment ends because the cancer can grow again. Breathlessness, tiredness, reduced appetite and weight loss can limit daily activity, and fluid may collect again and need further drainage. Many people find it helps to bring in palliative care early, to plan for changing needs at home and at work, and to talk through their wishes for future care while they can take full part in those decisions. Support for family members and caregivers matters too, since the illness affects the whole household.

When to Seek Help

If you have a history of asbestos exposure, tell your doctor, and arrange a visit if you develop shortness of breath, a cough that does not go away, pain under the rib cage, swelling or lumps in the abdomen, or weight loss you can't explain. These symptoms usually have more common causes, but the exposure history changes what the doctor looks for. During treatment, contact your oncology team right away if breathing becomes noticeably harder, which can mean fluid has built up again or the lungs are inflamed. On immunotherapy, also call them promptly about diarrhea or severe belly pain, yellowing of the skin or eyes, a new rash, or chest pain, because immune side effects respond best to early treatment.

Questions to Ask Your Doctor

  1. 1.What type and stage of mesothelioma do I have, and should the pathology be reviewed by a center with mesothelioma experience?
  2. 2.Is surgery a realistic option for me, and what would it involve and take away?
  3. 3.How do immunotherapy and chemotherapy compare for my cell type, and which side effects should I watch for?
  4. 4.What can we do if fluid keeps building up around my lung or in my abdomen?
  5. 5.Are there clinical trials I should consider, and when should palliative care become part of my care?

Last reviewed • Oct 2026

Educational content, not medical advice.